![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Grössmann, N. and Wolf, S. and Wild, C. (2016): Horizon Scanning in Oncology: Results of the 29th Prioritisation – 4th quarter 2016.. HSO: 29th Prioritisation.
Preview |
PDF
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
234kB |
Abstract
For the 29th prioritisation (December 2016) the following two drugs for the treatment of breast cancer were selected for an "early assessment": Neratinib and Ribociclib. Further information about these drugs including, for example, abstracts of phase III studies and licensing status is contained in this document.
| Item Type: | DSD: Horizon Scanning in Oncology |
|---|---|
| Subjects: | WB Practice of medicine > WB 300-962 Therapeutics QZ Pathology > QZ 200-380 Neoplasms.Cysts QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology |
| Language: | English |
| Series Name: | HSO: 29th Prioritisation |
| Deposited on: | 10 Jan 2017 18:13 |
| Last Modified: | 15 Jul 2020 17:55 |
Repository Staff Only: item control page